Lowenstein represented Ezra, the healthcare artificial intelligence (AI) company transforming MRI imaging and early cancer detection, in a $21 million fund raise that brings the company’s total funding to $41 million.
The investment will be used to accelerate the company’s expansion to 20 cities and 50 locations across North America in 2024, as well as advance the use of its AI technology by leading imaging centers and clinicians.
Ezra leverages FDA-cleared AI technology to reduce the time it takes to complete an MRI scan. By deploying its AIs at leading imaging centers, Ezra offers consumers the ability to access full-body MRI scanning at much more affordable pricing, and supports imaging centers in increasing throughput, efficiency, and affordability.
The round was co-led by Healthier Capital and FirstMark Capital, with participation from Allianz Life Ventures, Gaingels, Republic, and Mana Ventures. Existing investors Credo Ventures, Seedcamp, LDV Capital, Accomplice, Founders Future, also participated.
The Lowenstein team included Eric Weiner, Laura Cicirelli, Ed Zimmerman, Adam Dickson, Tina Aoun, Kathleen A. McGee, Abbey E. Baker, Henry M. Xu, Eric Sands, and Chynara Tolubaeva.
